L. Xu

Rifampicin induction of lidocaine metabolism in cultured human hepatocytes.

A. Li, D. Kaminski, A. Rasmussen, 1995, The Journal of pharmacology and experimental therapeutics.

Induction of cytochrome P450IA1 in rat hepatoma cell by polycyclic hydrocarbons and a dioxin.

E. Bresnick, L. Xu, 1990, Biochemical pharmacology.

Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells.

E. Bresnick, J. Weaver, L. Xu, 1993, Molecular pharmacology.

Effect of the histone deacetylase inhibitor trichostatin A on the responsiveness of rat hepatocytes to dioxin.

T. Ruh, M. Ruh, L. Xu, 1997, Biochemical pharmacology.

Induction of cytochrome P450IA1 and its recombinant construct in H4IIE rat hepatoma cells.

E. Bresnick, P. Sinclair, L. Xu, 1993, The International journal of biochemistry.

Presence of the 4 S polycyclic hydrocarbon-binding protein in H4-II-E cells.

E. Bresnick, W. Houser, L. Xu, 1991, Toxicology.

N-oxygenation of amphetamine and methamphetamine by the human flavin-containing monooxygenase (form 3): role in bioactivation and detoxication.

A. Janowsky, J. Cashman, L. Xu, 1999, The Journal of pharmacology and experimental therapeutics.

Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.

A. Li, J. Gorski, S. Hall, 1997, Chemico-biological interactions.

2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes.

A. Li, D. Kaminski, M. Ruh, 2000, Chemico-biological interactions.